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Objective: The purpose of this study was to prospectively compare pre-operative computed tomography (CT) perfusion 
parameters with tumor grade from colorectal adenocarcinoma (CRC) and to correlate pre-operative CT perfusion parameters 
with microvessel density (MVD) to evaluate angiogenesis in CRC. 
Materials and Methods: Pre-operative perfusion CTs were performed with a 64-channel multidetector row CT in 27 patients 
(17 women and 10 men; age range 32-82 years) who were diagnosed with CRC involving the sigmoid and rectum between 
August 2006 and November 2007. All patients underwent surgery without pre-operative chemotherapy or radiation therapy. 
Dynamic perfusion CTs were performed for 65 seconds after intravenous injection of contrast medium (100 mL, 300 mg of 
iodine per mL, 5 mL/sec). Before surgery, blood flow (BF), blood volume, mean transit time (MTT), and permeability- 
surface area product were measured in the tumor. After surgery, one gastrointestinal pathologist evaluated tumor grade and 
performed immunohistochemical staining using CD 34 to determine MVD in each tumor. The Kruskal-Wallis test was used to 
compare CT perfusion parameters with tumor grade, and Pearson’s correlation analysis was used to correlate CT perfusion 
parameters with MVD.
Results: In 27 patients with CRC, tumor grading was as follows: well differentiated (n = 8); moderately differentiated (n = 
15); and poorly differentiated (n = 4). BF was higher in moderately differentiated CRC than well differentiated and poorly 
differentiated CRCs (p = 0.14). MTT was shorter in moderately differentiated than well differentiated and poorly 
differentiated CRCs (p = 0.039). The MVD was greater in poorly differentiated than well differentiated and moderately 
differentiated CRCs (p = 0.034). There was no significant correlation between other perfusion parameters and tumor grade. 
There was no significant correlation between CT perfusion parameters and MVD.
Conclusion: BF and MTT measurement by perfusion CT is effective in predicting moderately differentiated CRCs. However, 
perfusion CT is limited in distinguishing well differentiated and poorly differentiated CRCs. Pre-operative perfusion CT does 
not reflect the MVD of CRCs.
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methods outlined here. Written informed consent was 
obtained from each patient or the patient’s family before 
the pre-operative CT scan, including administration of 
radiation dose, was performed. Patients were excluded from 
the study if the patient had renal disease that precluded 
performing a contrast-enhanced CT (serum creatinine level, 
> 1.9 mg/dL). Between August 2006 and November 2007, 
47 consecutive patients with CRC who underwent pre-
operative CT scans were prospectively enrolled in the study.
The following were exclusion criteria for the study: pre-
operative radiation therapy or chemotherapy (n = 5), 
descending or ascending colon cancers with severe motion 
artifact (n = 3), poor identification of the tumor due to size 
(< 1 cm in diameter) at planning CT for perfusion scan (n 
= 3), no surgical intervention (n = 7), inability to place an 
intravenous cannula (n = 1), and mucinous carcinoma (n = 
1). Thus, 27 consecutive patients (17 women and 10 men; 
mean age 59.3 years; range 32-82 years) who underwent 
pre-operative CT scans were prospectively enrolled in the 
study.
CT Technique
Pre-operative perfusion CT scans were performed 
with a 64 channel volume CT (Lightspeed VCT; GE 
Healthcare Technologies, Milwaukee, WI, USA) on all 
patients. To prevent peristaltic movement, 20 mg of the 
spasmolytic agent, hyoscine butylbromide (Buscopan®; 
Boehringer Ingelheim, Ingelheim am Rhein, Germany), 
was administered intravenously prior to data acquisition. 
Colonic dilatation with CO2 gas by automatic colon 
insufflators (protoCO2l; EZEM, Bicester, UK) was performed 
on all patients. Limited scout images were initially obtained 
from all patients in the lying position on the scanner table 
to identify colorectal tumor location by a supervising, 
experienced gastrointestinal radiologist before dynamic 
perfusion CT was performed. The scanning coordinates 
were used to plan the subsequent dynamic perfusion CT 
examination, which was focused on the mid-portion of the 
tumor. The following parameters for limited scout images 
were used: slice thickness, 5 mm; interval, 5 mm; scan type, 
helical mode; rotation speed, 1 sec; 80 Kvp, 200 mA, scan 
field of view, 33 cm; and matrix, 512 x 512 mm.
One hundred mL of iopramide (Ultravist®; Schering, 
Berlin, Germany) was injected intravenously at a rate of 5 
mL/s via an automatic pump injector for dynamic perfusion 
CT scans. Dynamic perfusion CT scans were performed at 
the mid-portion of the tumor for 60 seconds, beginning 
INTRODUCTION 
Colorectal adenocarcinoma (CRC) is the third most 
common cancer in the world, accounting for 8.9-9.4% of all 
cancers (1, 2). The worldwide prevalence of CRC is second 
only to that of breast cancer (2). The 5-year survival for 
poorly differentiated CRC (29%) is significantly less than 
well differentiated and moderately differentiated CRC (59%, 
p = 0.0002) (3). In addition, increased microvessel density 
(MVD) is correlated with poor outcome in CRC (4, 5). The 
histologic MVD technique is the current gold standard by 
which tumor angiogenesis is characterized (6). Several 
studies have shown a statistically significant correlation 
between MVD, invasion, and metastasis in various solid 
tumors such as breast, lung, uterine cervix, and prostate 
(6-12). Des Guetz et al. (13) reported that there is a 
statistically significant inverse relationship between 
angiogenesis, assessed by MVD or vascular endothelial 
growth factor expression, and survival in human invasive 
CRC.
Dynamic contrast-enhanced CT is also regarded as an 
appropriate non-invasive technique for assessment of 
angiogenesis, where positive correlations between CT 
parameters and immunohistologic measures, such as MVD, 
have been reported in studies of lung and kidney cancers 
(14). Goh et al. (14) reported that among perfusion 
parameters, the tumor permeability surface-area product (PS) 
and blood volume (BV) correlate positively with MVD and 
may reflect the degree of microvascularity within CRCs. In 
contrast, Li et al. (15) reported that there is no significant 
correlation between MVD and perfusion parameters in CRC. 
Indeed, debate continues regarding the correlation between 
MVD and CRC perfusion parameters, demonstrating the need 
for further investigation in this area of research.
Few studies have been conducted on the relationship 
between tumor grade and perfusion CT in CRC (1, 2). Thus, 
the purpose of the current study was to compare pre-
operative CT perfusion parameters with tumor grade of CRC 
and to evaluate the correlation between pre-operative CT 
perfusion parameters and MVD to evaluate angiogenesis in 
CRC.
MATERIALS AND METHODS
Patients
Prior to the beginning of this study, the Institutional 
Review Board approved of the experimental design and 
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5 seconds after contrast injection using the following 
parameters: slice thickness, 5 mm; interval, 5 mm; scan 
type, cine mode; 8 contiguous sections of 40 mm diameter; 
rotation speed, 0.5 sec; 80 Kvp; 200 mA; scan field of view, 
33 cm; and matrix, 512 x 512 mm. All patients underwent 
surgery without pre-operative chemotherapy or radiation 
therapy after perfusion CT was performed. 
Image Analysis
All CT scanning data were sent to a workstation 
(Advantage Windows 4.2; GE Healthcare Technologies). Two 
gastrointestinal radiologists (YYJ and JWK, with abdominal 
imaging experience of 15 and 3 years, respectively) 
reviewed the eight contiguous section images and selected 
one section image as having the best visualized tumor, 
with consensus. One gastrointestinal radiologist analyzed 
the selected 5 mm tumor section image by using perfusion 
software based on distributed parameter analysis (Body 
Protocol, Perfusion 3.0; GE Healthcare Technologies). An 
arterial input was defined by using a mouse to place a 
circular region of interest (ROI), 25 mm
2 in area, within 
the best visualized iliac or femoral artery on the selected 
image. The software automatically derived a smoothed 
arterial time-enhancement curve, and parametric maps were 
generated, with each pixel representing a parameter value.
Three circular or ovoid ROIs (mean area = 31.23 mm
2; range 
= 13-67 mm
2) were manually defined on the most enhanced 
area of the tumor. The ROIs of the tumor did not include 
central, poorly enhanced, low-attenuated areas, which were 
considered to be areas of necrosis or poorly vascularized 
areas within the tumor. Among three ROIs, the one with the 
highest attenuation was selected as the tumor ROI (mean 
area = 30.85 mm
2; range = 13-57 mm
2). Tumor blood flow 
(BF), BV, mean transit time (MTT), and PS measurements 
were obtained by manually defining a tumor ROI within 
the tumor boundary (Fig. 1). We took care to ensure that 
the tumor ROI remained within the tumor boundary, and 
excluded luminal gas when present, by viewing a cine loop 
of the perfusion CT images. The mean values for each of 
the four perfusion parameters (BF, BV, MTT, and PS) were 
recorded. 
Tumor Grade, Immunohistochemical Staining and 
Microvessel Density
The surgical specimens were fixed with 10% formaldehyde 
and embedded in paraffin, then the tumor specimens were 
divided by one gastrointestinal pathologist (JHL, with 
15 years of experience) into three histologic subgroups 
(well differentiated, moderately differentiated, and poorly 
differentiated CRC).
For evaluation of tumor angiogenesis, additional 
tissue blocks from each tumor were acquired for further 
immunohistochemical staining. The locations for additional 
tissue on tumor specimens were selected at the mid-portion 
of the tumor in the craniocaudal direction, then several 
4 μm-thick sections (range, 3-7 μm) acquired by 5 mm 
intervals along the cranial and caudal direction from the 
selected tumoral mid-portion. Particular care was taken to 
ensure additional tissue did not include necrotic portions of 
the tumor, if possible.
A representative paraffin block of 10% formalin-
fixed tumor tissue was cut to a thickness of 4 μm and 
immunohistochemical staining was carried out using 
a Microprobe Immuno/DNA stainer (Fisher Scientific, 
Pittsburgh, PA, USA). Immunohistochemical analysis of 
CD34 (titer 1:200, monoclonal; Zymed, San Francisco, CA, 
USA) was performed using the avidin-biotin complex method. 
Sections were deparaffinized, then incubated in the primary 
antibodies for 20 minutes at 45°C. Tissue sections for CD34 
were incubated in pepsin solution (Research Genetics, 
Huntsville, AL, USA) for 4 minutes before application of 
primary antibody. Anti-mouse immunoglobulin G (Sigma 
Chemical, St. Louis, MO, USA) labeled with biotin was 
used, and a secondary antibody for the detection of 
primary antibodies was incubated for 7 minutes at 45°C. 
The streptavidin-horseradish peroxidase detection system 
(Research Genetics, Huntsville, AL, USA) was then applied 
to capillary channels, followed by 10 minutes of incubation 
at 45°C. After drainage, the tissue sections were ready 
for chromogen reaction with 3,3’-diamino-benzidine. 
The sections were counterstained with hematoxylin and 
mounted in Universal Mount (Research Genetics, Huntsville, 
AL, USA). Negative controls were treated similarly, with the 
exception of primary antibodies.
Hot spot analysis was used as criteria for microvessel 
counting, as established by Weidner (16). The rationale of 
counting microvessels in vascular ‘hot spots,’ or in areas 
giving the impression at low magnification of containing 
numerous microvessels, is that these areas originated from 
tumor cell clones with the highest angiogenic potential, 
and consequently, had the easiest access to the blood 
stream and an increased probability of producing metastasis 
capable of becoming angiogenic and growing tumors (17). 
Any single brown-staining endothelial cell or small 
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clusters of brown-staining endothelial cells, with or without 
a lumen, clearly separate from adjacent microvessels, 
tumor cells, and other connective tissue elements, were 
considered as individual vessels. Vessels of a caliber larger 
than approximately eight red blood cells and vessels with a 
thick muscular wall were excluded from the final count. 
Fig. 1. Perfusion CT of rectal cancer in 68 year-old woman. 
A. Contrast-enhanced CT image shows tumor region of interests within enhancing rectal cancer (arrows) and arterial input (arrowhead) in left 
iliac artery. B-E. Corresponding functional color maps of rectal tumor (arrow) and iliac artery (arrowhead) for each perfusion parameter [(B) 
blood flow, (C) blood volume, (D) mean transit time, and (E) permeability surface-area product] are displayed according to color scale.
A
C
E
B
D
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Slides were examined at low-power magnification (x 
40) to identify the areas with the highest density of 
microvessels. In each case, the most vascularized area 
was selected and the microvessels within a high-power 
magnification (x 200) field of this area were counted 3 
times. The mean of the three highest counts per tumor was 
used for analysis (Fig. 2).
Statistical Analysis
The correlation between the four perfusion parameters 
(BF, BV, MTT, and PS) and MVD, and the three histologic 
grades of CRC was examined using the Kruskal-Wallis test. 
The correlation between perfusion parameters and MVD was 
analyzed using Pearson’s correlation analysis. All analyses 
were performed using the Statistical Package for the Social 
Sciences (SPSS, version 17; SPSS, Chicago, IL, USA). A value 
of p < 0.05 was considered significant.
RESULTS
All tumors were histologically proven to be non-mucinous 
CRCs after surgery. The mean interval between pre-operative 
CT scan and surgery was 23.5 days (range of 7-75 days). 
Of 27 CRCs, there were 8, 15, and 4 well differentiated, 
moderately differentiated, and poorly differentiated CRCs, 
respectively. The tumors were located in the rectum and 
sigmoid colon in 23 and 4 patients, respectively. There were 
3 T2 tumors, 21 T3 tumors, and 3 T4 tumors.
The correlation of perfusion parameters and tumor grade 
is summarized in Table 1. The mean BF was significantly 
higher in moderately differentiated than well differentiated 
and poorly differentiated CRCs (p = 0.014). The mean 
MTT was significantly shorter in moderately differentiated 
compared with well differentiated and poorly differentiated 
CRCs (p = 0.039). There was no significant correlation 
between the other perfusion parameters (BV and PS) and 
tumor grade (p > 0.05). The MVD was significantly greater 
in poorly differentiated than well differentiated and 
moderately differentiated CRCs (p = 0.034) (Table 1, Fig. 3).
The Pearson’s correlation coefficients (r) and p values 
between the four perfusion parameters (BF, BV, MTT, and 
PS) and MVD in CRCs are summarized in Table 2. There 
was no significant correlation between the four perfusion 
parameters and MVD in CRCs (Fig. 4).
DISCUSSION
Our study showed that the mean BF was significantly 
lower in poorly differentiated than well differentiated and 
moderately differentiated CRCs. There was no significant 
difference between tumor grades with respect to the other 
perfusion parameters. Among the four perfusion parameters 
(BF, BV, MTT and PS), it is well known that BF reflects the 
flow rate through the vasculature in the tissue region and 
is related to tumor vascularity and tumor grade. In general, 
as the tumor grade is higher, the BF value further increases. 
Dugdale et al. (18) demonstrated a correlation between 
higher tumor BF and higher grade of lymphoma based on 
histopathologic examination. There are some conflicting 
results between previous reports and our study. These 
observations stand in contrast to the conventional belief 
that high-grade tumors have increased vascularity. Contrary 
to current dogma, Sahani et al. (19) reported that the 
mean BF values were higher in well differentiated HCC than 
in moderately differentiated or poorly differentiated HCCs. 
They suggested that a relatively larger tumor diameter 
(mean of 9 cm) and the presence of tumor necrosis in the 
high-grade tumor group could account for their results. 
There were several problems in comparing directly HCC and 
CRC because HCC and CRC are different in tumor nature 
and behavior. We found that the vascularities of CRC were 
increased in moderately differentiated CRCs compared 
to well differentiated CRCs, and decreased in poorly 
differentiated CRCs compared to moderately differentiated 
and well differentiated CRCs. There are two hypotheses to 
Fig. 2. Increased CD34 immunostaining in moderately 
differentiated colorectal adenocarcinomas was observed. 
Microvessels were defined as single brown-staining endothelial cells 
with lumen (arrow) and small clusters of brown-staining endothelial 
cells without lumen (arrowhead) (CD34 immunostaining at x 200 
magnification).
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account for our results. First, the growth rate of CRCs was 
too rapid to develop angiogenesis of mature vessels in 
poorly differentiated CRCs. Second, poorly differentiated 
CRCs have larger regions in which endothelial cells have 
high vascular permeability, therefore the interstitial pressure 
will increase and can compress the capillary sprouts and 
Fig. 3. Relationship between CT perfusion parameters (A-D) and microvessel densities (E) of well differentiated, moderately 
differentiated, and poorly differentiated colorectal adenocarcinoma (CRC). There were significant differences in blood flow (A), mean 
transit time (C), and microvessel densities (E) between well differentiated, moderately differentiated, and poorly differentiated CRC (p < 0.05).
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small capillaries more than in well differentiated and 
moderately differentiated CRCs. 
Our study showed that the mean MTT was significantly 
shorter in moderately differentiated than in well 
differentiated and poorly differentiated CRCs. It is well 
established that the MTT is defined as the average time 
required to travel from the artery to the vein; the MTT is 
considered to be a marker of perfusion pressure. Sahani 
et al. (19) reported that well differentiated HCCs had a 
shorter MTT and higher BF than moderately differentiated 
and poorly differentiated HCCs. Our study showed that 
moderately differentiated CRCs had a shorter MTT and higher 
mean BF than well differentiated and poorly differentiated 
CRCs, thus the results in the current study are similar to of 
the results of Sahani et al. (19)
MVD assessment is the most commonly used technique 
to quantify intratumoral angiogenesis in cancer (13). Our 
study also showed a correlation between tumor grades and 
MVD. Tumor vessels, irrespective of tumor size, demonstrate 
a zonal distribution in which vascularity decreases from 
the tumor edge to the center (20, 21). As the tumor grows, 
the central portions become relatively hypovascular and 
eventually necrotic. MVD is a surrogate marker of tumoral 
angiogenesis and has been proposed to identify patients at 
high risk of recurrence, since high values of MVD have been 
correlated with poor outcome in CRC (4, 5). This association 
is greatest when measurements of MVD are restricted to 
the peripheral angiogenesis zone (20, 22). However, other 
studies suggest that the relationship between MVD and CRC 
is controversial (6, 8, 15). Chen et al. (23) reported that 
the gross enhancement morphology of HCC lesions is also 
correlated with tumor MVD, and reflects the distributive 
features of tumor microvessels within HCC lesions. Jinzaki 
et al. (24) reported that the enhancement pattern on CT 
was different among the subtypes of RCCs, and correlated 
with either MVD or with the existence of intratumoral 
Fig. 4. Correlation plots of microvessel density (MVD) and CT vascular parameters. (A) blood flow, (B) blood volume, (C) mean transit 
time, and (D) permeability surface-area product. No perfusion parameters correlated significantly with MVD.
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necrosis or hemorrhage. Therefore, we hypothesized that the 
enhanced area of tumors without necrosis in defining tumor 
ROI reflects MVD for angiogenesis more than including the 
entire tumor with a central, poorly vascularized area in CRC. 
Our study used an enhanced focal area as a tumor ROI “so 
called hot spot analysis” rather than the entire tumoral 
area. Hot spot analysis is a widely performed technique 
that has been shown to yield results that are reflective 
of both tumor neovascularization and prognosis (13, 
17). In poorly differentiated CRCs, MVD was significantly 
increased compared to well differentiated and moderately 
differentiated CRCs. However, there was no significant 
correlation between perfusion parameters and MVD. The 
results are similar to the findings reported by Li et al. (15). 
The study defined the maximally enhanced large area of the 
tumor as the tumor ROI and there was no clinical correlation 
between MVD and perfusion parameters. In contrast, Goh 
et al. (14) reported that the tumor PS and BV correlate 
positively with MVD and may reflect the microvascularity of 
CRCs. They defined the entire area of the tumor on selected 
CT images as the tumor ROI and used two counting methods 
of systematic field and hot spot analysis (17, 25). However, 
there is a paucity of CRC data using systemic field analysis 
with the former approach. This difference in the methods 
of defining tumor ROI and microvessel counting between 
our study and the study of Goh et al. (14) may be one 
of the causes accounting for the different results, and as 
such there is still a need for standardization of microvessel 
counting. Because tumor angiogenesis can be assessed with 
different microvessel counting methods, the issue of which 
method is the most effective remains controversial (26). 
There were several limitations to our study. First, the 
study sample size was small and there were few cases 
of poorly differentiated CRCs because the prospective 
consecutive selection of patients was done prior to surgery. 
Accordingly, a study with a larger number of patients is 
needed. Second, there is no precise correlation between 
tumor ROI in perfusion CT and pathologic specimen after 
surgery. Third, radiation hazards still remain a limitation 
in perfusion CT. Nevertheless, as CT machines and software 
have been developed and additional research is performed, 
the radiation dose of perfusion CT to patients may decrease. 
In conclusion, BF and MTT may be effective and clinically 
useful in the prediction of moderately differentiated CRCs, 
although the BV and PS are not effective in prediction of 
tumor grade in CRCs. Pre-operative perfusion CT does not 
reflect MVD of CRCs.
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